WVE – wave life sciences ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $38.00 price target on the stock.
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $34.00 to $41.00. They now have an "overweight" rating on the stock.
Wave Life Sciences price target raised to $50 from $47 at Clear Street [Yahoo! Finance]
WAVE Life Sciences (NASDAQ:WVE) was given a new $43.00 price target on by analysts at Canaccord Genuity Group Inc..
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency [Yahoo! Finance]
Form SCHEDULE 13G Wave Life Sciences Ltd. Filed by: FMR LLC
Form 8-K Wave Life Sciences Ltd. For: Feb 02
Form 8-K Wave Life Sciences Ltd. For: Jan 12
Form 4 Wave Life Sciences Ltd. For: Jan 02 Filed by: Francis Chris
Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.